56 related articles for article (PubMed ID: 33098134)
1. Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.
Chen JJ; Jin ZC; Zhong BY; Fan W; Zhang WH; Luo B; Wang YQ; Teng GJ; Zhu HD
United European Gastroenterol J; 2024 Mar; 12(2):226-239. PubMed ID: 38372444
[TBL] [Abstract][Full Text] [Related]
2. Immune Effects of Intra-Arterial Liver-Directed Therapies.
Karimi A; Yarmohammadi H; Erinjeri JP
J Vasc Interv Radiol; 2024 Feb; 35(2):178-184. PubMed ID: 38272638
[TBL] [Abstract][Full Text] [Related]
3. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC.
Biondetti P; Saggiante L; Ierardi AM; Iavarone M; Sangiovanni A; Pesapane F; Fumarola EM; Lampertico P; Carrafiello G
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830949
[TBL] [Abstract][Full Text] [Related]
4. Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation.
Crocetti L; Bozzi E; Scalise P; Bargellini I; Lorenzoni G; Ghinolfi D; Campani D; Balzano E; De Simone P; Cioni R
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771720
[TBL] [Abstract][Full Text] [Related]
5. Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study.
Manzia TM; Lai Q; Iesari S; Perera MTPR; Komuta M; Carvalheiro A; Shah T; Angelico R; Quaranta C; Nicolini D; Montalti R; Scarpelli M; Palmieri G; Orlacchio A; Vivarelli M; Angelico M; Lerut J; Tisone G
Transpl Int; 2018 Mar; ():. PubMed ID: 29572974
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues.
Marrone G; Leone MS; Biolato M; Liguori A; Bianco G; Spoletini G; Gasbarrini A; Miele L; Pompili M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067299
[TBL] [Abstract][Full Text] [Related]
7. Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game.
Rubin A; Berenguer M
Transpl Int; 2018 Apr; ():. PubMed ID: 29710433
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Cescon M; Cucchetti A; Ravaioli M; Pinna AD
J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
[TBL] [Abstract][Full Text] [Related]
9. Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-transplant Clinical Outcome.
Adeniji N; Arjunan V; Prabhakar V; Tulu Z; Kambham N; Ahmed A; Kwo P; Dhanasekaran R
Clin Transplant; 2020 Dec; 34(12):e14128. PubMed ID: 33098134
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
11. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.
El-Gazzaz G; Sourianarayanane A; Menon KV; Sanabria J; Hashimoto K; Quintini C; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):34-41. PubMed ID: 23392796
[TBL] [Abstract][Full Text] [Related]
12. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
[TBL] [Abstract][Full Text] [Related]
13. Bridging to liver transplantation in HCC patients.
Kollmann D; Selzner N; Selzner M
Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
[TBL] [Abstract][Full Text] [Related]
14. Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
Benkö T; König J; Theysohn JM; Schotten C; Saner FH; Treckmann J; Radunz S
Eur J Med Res; 2022 May; 27(1):74. PubMed ID: 35619164
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
